0001209191-23-038804.txt : 20230621
0001209191-23-038804.hdr.sgml : 20230621
20230621164033
ACCESSION NUMBER: 0001209191-23-038804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dubovsky Filip
CENTRAL INDEX KEY: 0001977361
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 231030433
MAIL ADDRESS:
STREET 1: C/O NOVAVAX INC.
STREET 2: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-16
0
0001000694
NOVAVAX INC
NVAX
0001977361
Dubovsky Filip
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
President, R&D
0
Common Stock
2023-06-16
4
M
0
4155
8.04
A
47065
D
Common Stock
2023-06-16
4
F
0
2007
8.04
D
45058
D
Restricted Stock Units
2023-06-16
4
M
0
4155
0.00
D
Common Stock
4155
0
D
The shares were received by the reporting person in connection with vesting of restricted stock units ("RSUs").
Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 16, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2023-06-21